Triangularine B



Compound IDCDAMM01348
Common nameTriangularine B
IUPAC name12-methoxy-14-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-3,5-dioxa-10-azapentacyclo[9.7.1.02,6.08,19.013,18]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one
Molecular formulaC29H31NO15

Experimental data

Retention time16.94
Adduct[M+H]+
Actual mz634.181
Theoretical mz634.176
Error6.82
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.4135

Identifiers and class information

Inchi keyGNZQTFWPRCGKGK-XGFWTJGFNA-N
SmilesO=C1NC=2C(OC)=C3C(OC4OC(COC5OC(CO)C(O)C(O)C5O)C(O)C(O)C4O)=CC=CC3=C6C=7OCOC7C=C1C26
SuperclassAlkaloids and derivatives
ClassAristolactams

Pharmacokinetic properties

Number of descriptor values(#stars)8
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)14
Number of reactive functional groups (#rtvFG)3
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)633.562
Computed dipole moment(dipole)7.631
Total solvent accessible surface area (SASA)844.585
Hydrophobic component of SASA (FOSA)347.646
Hydrophilic component of SASA (FISA)319.016
Pie component of the SASA (PISA)177.924
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1619.57
Number of hydrogen bond donors (donorHB)8
Number of hydrogen bond acceptors (accptHB)22.5
Free energy of solvation of dipole (dip^2/V)0.0359548
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0753502
Globularity descriptor (glob)0.789686
Predicted polarizability in cubic angstroms (QPpolrz)51.371
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.616
Predicted octanol/gas partition coefficient (QPlogPoct)41.95
Predicted water/gas partition coefficient (QPlogPw)35.923
Predicted octanol/water partition coefficient (QPlogPo/w)-2.153
Predicted aqueous solubility (QPlogS)-2.481
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.053
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.784
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)9.347
Predicted brain/blood partition coefficient (QPlogBB)-3.691
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)3.169
Predicted skin permeability, log Kp (QPlogKp)-5.428
PM3 calculated ionization potential (IP(ev))8.237
PM3 calculated electron affinity (EA(eV))1.382
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)-1.503
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)239.88
Number of nitrogen and oxygen atoms (#NandO)16
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P60568IL2Interleukin-2T61698SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
P14679TYRTyrosinaseT97035SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P05231IL6Interleukin-6T32578SEA
Q99417MYCBPMYCBP messenger RNAT37298SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T32578DI0028Anemia[ICD-11: 3A00-3A9Z]P05231IL6
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025